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Abstract. ERGIC-53 is a lectin-type membrane pro- 
tein that continuously recycles between the ER, ER- 
Golgi intermediate compartment (ERGIC) and the cis- 
Golgi. To identify  the targeting signals that mediate this 
recycling, N-glycosylated and myc-tagged variants of 
ERGIC-53 were constructed. By monitoring endogly- 
cosidase H resistance, we measured the loss from the 
ER-ERGIC-cis-Golgi cycle of ERGIC-53. A domain 
exchange approach with the plasma membrane re- 
porter protein CD4 showed that the transmembrane 
and the lumenal domains are not sufficient, while the 
cytoplasmic domain of ERGIC-53 is required and suffi- 
cient for pre-medial-Golgi localization. However, the 
ERGIC-53 cytoplasmic domain on CD4 lead to in- 
creased ER-staining by immunofluorescence  micros- 
copy indicating that this domain alone cannot provide 
for unbiased recycling through the ER-ERGIC-cis- 
Golgi compartments. Complete progress through the 
ER-ERGIC-cis-Golgi recycling pathway requires the 
cytoplasmic domain acting together with the lumenal 
domain of ERGIC-53. Dissection of the cytoplasmic 
domain revealed a COOH-terminal di-lysine ER- 
retrieval signal, KKFF, and an RSQQE targeting deter- 
minant adjacent to the transmembrane domain. Sur- 
prisingly, the two COOH-terminal phenylalanines 
influence the targeting. They reduce the ER-retrieval 
capacity of the di-lysine signal and modulate the 
RSQQE determinant. 
OCALIZATION of resident membrane proteins  in  the 
secretory  pathway  is  achieved  by  two  targeting 
mechanisms: protein retention and retrieval of trans- 
ported proteins from a later compartment (Pelham and 
Munro, 1993; Nilsson and Warren, 1994). 
Protein retention describes a process by which proteins 
are  excluded from incorporation into transport vesicles. 
Such  a  process  has been reported for Golgi  membrane 
proteins:  the M-protein of avian coronavirus forms large 
homooligomers in the cis-Golgi via its transmembrane do- 
mains  leading  to  large  aggregates  unable  to  enter  the 
coated bud (Swift and Machamer et al., 1991; Machamer 
et aL, 1993; Weisz et al., 1993). A similar type of aggregate 
was proposed to form between glycosylation enzymes of 
the Golgi apparatus which are known to be retained by 
their transmembrane domains (Nilsson et al., 1991; Munro, 
1991; Aoki et al., 1992; Burke et al., 1992; Colley et al., 
1992; Russo et al., 1992; Tang et al., 1992; Teasdale et al., 
1992; Wong et al., 1992). Since the concentration of Golgi 
glycosylation enzymes cannot reach that of a viral protein, 
Golgi  enzymes are  believed  to  form large  heterooligo- 
meric complexes  by kin recognition (Nilsson et al., 1993). 
Although  a  direct  heterooligomeric interaction  among 
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Golgi proteins remains to be shown, the kin recognition 
hypothesis is supported by the observation that artificial 
retention in the ER of the medial-Golgi enzyme GlcNAc- 
transferase  results  in  the  retention  of  another medial- 
Golgi enzyme, mannosidase II (Nilsson et al., 1994). 
Localization by protein retrieval is a fundamentally dif- 
ferent process.  Here, membrane proteins enter budding 
vesicles  and  are  transported  to  the  next  compartment, 
where they are recognized  by a receptor and sorted into 
vesicles destined for recycling to the compartment of ori- 
gin  (Pelham and Munro, 1993). Such  a  process  was de- 
scribed for type I membrane proteins of the ER that con- 
tain a COOH-terminal di-lysine ER-retrieval signal, KKXX 
or KXKXX, in their cytoplasmic  domain (Jackson et al., 
1990). In mammalian and in yeast cells these proteins can 
leave the ER and recycle  from a post-ER compartment 
(Jackson et al., 1993; Gaynor et al., 1994; Townsley et al., 
1994). Di-lysine  signals were shown to bind coatomer in 
vitro  (Cosson  and  Letourneur,  1994) and  mutations in 
yeast coatomer subunits  effect the intracellular retention 
of di-lysine  proteins  in  vivo  (Letourneur et  al.,  1994). 
These  findings  support  a  coatomer-mediated  retrieval 
mechanism for di-lysine ER proteins. 
The mannose-specific lectin ERGIC-53 (Schindler et al., 
1993; Arar et al., 1995) is predominantly associated with the 
ER-Golgi intermediate compartment (ERGIC)  1 (Schwei- 
1. Abbreviations used in this paper: ERGIC, ER-Golgi intermediate com- 
partment; endo H, endoglycosidase H. 
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ERGIC-53 and its rat homologue p58 (Saraste and Svens- 
son, 1991)  are also present at lower concentrations in the 
rough ER and in the first fenestrated cis-cisternae of the 
stacked Golgi (Foguet, M., and H.-P. Hauri, unpublished 
observation; Schweizer et al., 1988; Chavrier et al., 1990). 
ERGIC-53 is a  53-kD nonglycosylated type I  transmem- 
brane protein that assembles into equal amounts of disul- 
fide-linked homodimers and homohexamers (Schweizer et 
al., 1988; Schindler et al., 1993). It has a large lumenal do- 
main exhibiting homology to leguminous lectins and mam- 
malian galectins, a single transmembrane segment, and a 
short 12-amino acid long cytoplasmic domain (Schindler 
et al.,  1993; Fiedler and Simons, 1994; Arar et al., 1995). 
The cytoplasmic domain contains a  COOH-terminal tet- 
rapeptide, KKFF, matching the consensus for a di-lysine 
ER-retrieval signal. 
We show that targeting of ERGIC-53 cannot be explained 
by a simple retrieval mechanism, since proper localization 
required the lumenal and the cytoplasmic domains.  The 
cytoplasmic domain possesses  three  determinants  all  of 
which are required for correct targeting within the ER- 
ERGIC-cis-Golgi  recycling pathway: a functional di-lysine 
ER-retrieval signal, KKFF, a targeting determinant adja- 
cent to the membrane, RSQQE, and two COOH-terminal 
phenylalanines that reduce the retrieval efficiency of the 
di-lysine signal and modulate the RSQQE targeting deter- 
minant. Thus the ER-retrieval signal, although critical for 
retaining  ERGIC-53  in  the  ER-ERGIC-cis-Golgi  recy- 
cling pathway, is not sufficient for the correct distribution 
throughout these compartments. Targeting of ERGIC-53 
depends on a complex interplay of multiple determinants. 
Materials and Methods 
Materials 
Monoclonal antibodies  used included HP2/6.1  (IgG2A)(Carrera  et  al., 
1987)  and 6D10  (IgG1)  against human CD4.  In addition the following 
mAb hybridoma supernatants (N10-fold concentrated by ammonium sul- 
fate precipitation) were used: 9E10.2 (IgG1)(Evan et al., 1985)  against a 
c-myc epitope  (ATCC CRL  1729;  American Type Culture  Collection, 
Rockville, MD), G1/93 (IgG1) against ERGIC-53 (Schweizer et al., 1988), 
G1/221  (IgG1)  against  human transferrin  receptor,  G1/296  (IgG12A) 
against p63 (Schweizer et al., 1993),  G1/133 (IgG1) against giantin (Lin- 
stedt and Hauri, 1993).  [35S]methionine was isolated from Escherichia coli 
grown under sulfur-limited conditions in the presence of [35S]sulfate (New 
England Nuclear, Boston, MA). Protease inhibitors (used at the following 
final concentration 1 ~g/ml pepstatin, 1 p~g/ml aprotitin, 0.5 ~Lg/ml  leupep- 
tin, 1 ixg/rrd benzamidin, 1 i-~g/ml  antipain, and 0.2 mM phenylmethylsulfonyl 
fluoride), cycloheximide and nocodazole were from Sigma Chem. Co. (St. 
Louis, MO). 
Recombinant DNAs 
The c-myc epitope tagged and N-glycosylated form of ERGIC-53 desig- 
nated GM is shown in Fig. 1. The DNA sequence coding for the c-myc 
epitope EQKLISEEDL was introduced after the signal sequence at the 
amino acid position 31 of ERGIC-53 by PCR-based splicing (Horton et 
al., 1989).  The PCR amplified DNA was cloned back to the ERGIC-53 
cDNA (Schindler et al., 1993) via the Sacll site at position 116 leading to 
P53cmyc. In a  second reaction aspartic acid at position 61  of wild-type 
ERGIC-53 was mutated to asparagine by PCR mutagenesis (Ho et al., 
1989)  leading to a NGT N-glycosylation consensus site. The PCR-ampli- 
fled DNA was ligated to the ERGIC-53 cDNA via the BglI restriction site 
at position 269.  This construct was termed P53G1. The relegated DNA 
was treated with Klenow and cloned into the EcoRV site of Bluescript SK 
vector (Stratagene, La Jolla, CA). Both constructs were cloned into pECE 
to test for expression in COS cells. To create the final GM construct the 
two  mutations were  combined by  ligating the  cmyc tagged  5'-end  of 
P53cmyc via the SacI site at position 116 to P53G1. For expression in COS 
cells GM was cloned as a SalI/XbaI fragment into the pECE expression 
vector (Ellis et al., 1986). All mutations were confirmed by DNA-sequenc- 
ing (Sequenase 2.0; US Biochemical Co., Cleveland, OH). 
For further mutagenesis, GM was cloned as a ClaI/XbaI fragment into 
AccI/XbaI cut pECE. The resulting plasmid was designated pECE*. This 
cloning step eliminated the single AccI site in pECE so that the Accl site 
in GM at position 1429 became unique. All further constructs which con- 
tained  the  ERGIC-53  lumenal domain were  generated by  PCR  using 
3'-primers with a terminal XbaI restriction site. This allowed direct clon- 
ing of the PCR-amplified sequences as AccI/XbaI fragments into pECE* 
that were then confirmed by sequencing. 
Chimeric proteins between ERGIC-53  and human CD4  (Maddon et 
al., 1985)  were constructed by PCR based splicing by overlap extension 
(Horton et al., 1989). L4T53C53 was entirely generated by PCR introduc- 
ing a EcoRI site at the 5'- and a BamHI site at the 3'-end of the coding se- 
quence. This construct was fully sequenced. The PCR amplified sequences 
of all further constructs containing the CD4 lumenal domain were ligated 
back to the IMT53C53 DNA via either the TaqI site at position 1129 of the 
human CD4 cDNA or the AvaI site at position 1197. These DNAs were 
treated with Klenow, ligated into the EcoRV site of Bluescript SK, and 
confirmed by sequencing. For expression in mammalian cells these con- 
structs were cloned into pCB6 (Brewer and Roth, 1991); CD4, I.AT53C53 
as  EcoR/BamHI  fragments,  L4T4C53  as  an  EcoRI  and  LAT4C53 
K(-4)stop as a EcoRI/XbaI fragment. 
Cell Culture and Transfection 
COS-1 cells were grown in DME supplemented with 10% FCS, 100 IU/ml 
penicillin, 100 p.g/ml streptomycin, and 1 ixg/ml fungizone. COS cells were 
transfected using the DEAE-Dextran method (Cullen, 1987).  2 p.g DNA 
per 35-mm dish was used. 
Immunofluorescence 
All immunofluorescence  experiments were carried out in eight-well multi- 
chamber glass slides (Miles Labs, Naperville, IL). 42-48 h after transfec- 
tion the slides were fixed with paraformaldehyde and processed for indi- 
rect immunofluorescence. Saponine-permeabilized cells were stained as 
described (Schweizer et al., 1988). Primary antibody dilutions were as fol- 
lows: anti-ERGIC-53 (G1/93) 1:50 for endogenous ERGIC-53; 1:2,000 for 
overexpressed ERGIC-53; anti-c-myc epitope (9E10.2) 1:50; anti human 
CD4:HP2/6.1  1:150 (10x concentrated culture supernatant), HP2/6.1 as- 
cites 1:4000, 6D10 1:50; anti-giantin (G1/133) 1:50; anti-p63 (G1/296) 1:50; 
anti-transferrin receptor (G1/221) 1:50. 
For surface staining of ERGIC-53 and mutants the cells were cooled to 
4°C for 20 min followed by an incubation with G1/93 or 9E10.2 at a  1:10 
dilution in 250 txl culture medium for 30 rain. After six washes with culture 
medium the cells were fixed with 3% paraformaldehyde, pH 8.3,  for 30 
min. Thereafter the cells were rewarmed to room temperature, fixed for 
another 30 min, washed twice with PBS and twice with PBS containing 20 
mM glycine, and then permeabilized for 20 min with PBS-glycine contain- 
ing 0.1% saponine. The cells were then subjected to indirect immunofluo- 
rescence microscopy as described below. For differential staining of the 
cell surface and intraceUular structures of CD4 and CD4/ERGIC-53 chi- 
meric proteins the following double-immunofluorescence protocol  was 
applied. The cells were cooled to 4°C for 20 min followed by an incubation 
with mAb 6D10 at a dilution of 1:10 in culture medium for 30 min. After 
six washes with culture medium the cells were reincubated with IgGl-spe- 
cific  FITC-labeled affinity-purified goat anti-mouse secondary antibody 
(Cappel, West Chester, PA) for 30 rain, washed again six times with cul- 
ture medium, and fixed with 3% paraformaldehyde, pH 8.3,  for 30 min. 
Thereafter the cells were rewarmed to room temperature, fixed for an- 
other 30 rain, washed twice with PBS and twice with PBS containing 20 
mM glycine, and then permeabilized for 20 min with PBS-glycine contain- 
ing 0.1% saponine. The cells were then incubated with HP2/6.1 at a 1:150 
dilution in PBS-saponine for 30 min, washed four times with PBS-sapo- 
nine, and incubated with rhodamine (TRITC)-labeled IgG2a-specific af- 
finity-purified goat anti-mouse secondary antibody (Cappel)  for 30 min. 
After four final washes with PBS-saponine the cells were mounted in 90% 
glycerol, 10% PBS, and 0.1 mg/ml phenylenediamine. The cells were ana- 
lyzed by a Reichert Polyvar immunofluorescence microscope. 
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42 h after transfection the cells were washed once with PBS, incubated in 
labeling medium (PBS, 20% dialyzed FCS, 100 IU/ml penicillin, 100 g,g/ml 
streptomycin, 1% nonessential amino acids) for 15 min at 37°C and pulsed 
for 5 rain at 370C with 20 txCi [35S]methionine in 200 Ixl labeling medium 
per 35-mm dish. The cells were washed once with cold DMEM containing 
10 mM methionine and then chased in DMEM  containing 10 mM me- 
thionine at 37°C. The dishes were transferred to ice and all the subsequent 
steps were carried out on ice. The cells were washed twice with PBS, once 
with 100 mM sodium phosphate, 1% bovine serum albumin, pH 8, scraped 
off with a rubber policeman in 1 ml solubilization buffer (100 mM sodium 
phosphate, 1% Triton X-100, pH 8, and protease inhibitors), and passed 
five times through a 25-gauge needle. After incubation for 60 min the ly- 
sate was centrifuged at 100,000 g for 60 min, the resulting supernatant was 
incubated with either 2 ixl G1/93 ascites, 20 I~19E10.2, or 20 Ixl HP2/6.1 for 
60 min followed by an incubation with 2 t~1 rabbit anti-mouse IgG (Cap- 
pel) for 30 min. Immunocomplexes were isolated by adding 10 Ixl protein 
A-Sepharose (Pharmacia, Uppsala, Sweden), rotated over night at 4°C, 
washed four times with solubilization buffer, once with 100 mM sodium 
phosphate, pH 8, and once with 10 mM sodium phosphate, pH 8. Proteins 
were eluted from the protein A beads by boiling in electrophoresis sample 
buffer.  For  nonreduced  samples 4-10%,  for  reduced  samples  7-10% 
SDS-polyacrylamide gradient slab gels (Laemmli, 1970)  were run, salicy- 
lated, and visualized by fluorography using Kodak X-omat AR or Fuji RX 
films. 
Endoglycosidase H Digestion 
Immunoprecipitates were released from the protein A-Sepharose beads 
by boiling for 3 min in 30 Ixl 200 mM Na-citrate, pH 5.5, 2% SDS in the 
presence of protease inhibitors, frozen at  -20°C for 30 rain, and boiled 
again for 3 min. Then the samples were diluted with an equal volume of 
distilled water containing protease inhibitors and incubated with 4 mU en- 
doglycosidase H  (endo H) for 22 h at 37°C. 
Results 
Characterization  of the Epitope-tagged 
and N-glycosylated ER  GIC-53 
ERGIC-53  has  no  posttranslational  modifications  that 
would allow to monitor changes in intracellular localiza- 
tion (Schweizer et at., 1988).  To study loss of pre-medial- 
Golgi targeting directly we constructed a  N-glycosylated, 
epitope-tagged variant of ERGIC-53 (Fig. 1, GM). We used 
this  construct to measure  ER  to medial-Golgi transport 
rates in pulse-chase experiments based on the acquisition 
of endo H  resistance of its glycan moiety. Acquisition of 
endo H  resistance is a medial-Golgi event, and therefore 
reflects the  fraction of ERGIC-53  that  has  escaped  the 
ER-ERGIC-cis-Golgi  cycle. 
To determine if ERGIC-53 (GM) behaves identical to 
overexpressed wild-type ERGIC-53, COS-1 cells were tran- 
siently transfected with the corresponding DNAs and ana- 
lyzed by pulse-labeling with  [35S]methionine followed by 
immunoprecipitation, or by indirect immunofluorescence 
microscopy. The introduced c-myc epitope tag was recog- 
nized by the epitope-specific mAb 9E10 (Evan et al., 1985) 
both in indirect immunofluorescence experiments (Fig. 2, 
e and f) and immunoprecipitation (Fig. 3). In pulse-chase 
experiments GM and overexpressed wild-type ERGIC-53 
displayed virtually identical expression levels and  oligo- 
merization (Fig. 3), and the localization revealed by immu- 
nofluorescence  microscopy  indicates  that  the  modifica- 
tions did not alter the intracellular distribution compared 
to overexpressed wild type (Fig. 2). However, both over- 
expressed proteins showed a staining of the cell periphery 
Figure  1.  Schematic  representation  of  ERGIC-53  domain- 
exchanged constructs. ERGIC-53 constructs contain a N-glycosy- 
lation  site introduced at amino  acid position  61 of ERGIC-53, 
(CHO), and a c-myc epitope tag introduced after the signal se- 
quence cleavage site, (MYC). The amino acid sequence of the cy- 
toplasmic domain of the ERGIC-53 constructs is given in the sin- 
gle letter code. L, lumenal domain; T, trans-membrane domain; 
C, cytoplasmic domain; 4, CD4; 53, ERGIC-53.  The transmem- 
brane domain T53 consists of the hydrophobic  residues 481-498 
of ERGIC-53  (Schindler et al., 1993) and T4 comprises the hy- 
drophobic residues 375-395 of human CD4 (Maddon et al., 1985). 
typical for ER, and led to a comparable fraction of trans- 
fected ceils exhibiting surface staining (compare Fig. 2, c 
and  d  with e  and f).  Cells  expressing identical levels of 
ERGIC-53  or  GM  bound  equal  amounts  of radio-iodi- 
nated mAb to ERGIC-53 suggesting identical loss of both 
proteins  from the  ER-ERGIC-cis-Golgi  recycling path- 
way (data not shown). After immunoprecipitation of GM 
with mAb 9El0 against the c-myc epitope, digestion with 
endo  H  confirmed  that  the  introduced  N-glycosylation 
consensus  site  was  glycosylated and  that  the  oligomer- 
ization state  of GM  was  identical to that  of ERGIC-53 
(Fig.  3).  The  kinetics  of oligomerization of endogenous 
ERGIC-53  in  nontransfected  cells  and  that  of  overex- 
pressed GM or ERGIC-53 in transfected cells was identi- 
cal (not shown), indicating that the overall folding of GM 
is  indistinguishable  from ERGIC-53,  and  overexpressed 
ERGIC-53  and  GM  showed the  same  half-life in  pulse- 
chase experiments (not shown). In Fig. 3 hardly any en- 
dogenous  ERGIC-53  is  coprecipitated  with  GM  dem- 
onstrating that disulfide-linked heterooligomers between 
GM and endogenous ERGIC-53 should not influence the 
interpretation of a mutational analysis. We conclude that 
overexpression of the GM construct in COS-1 cells fulfills 
the criteria required for a mutational analysis of the tar- 
geting determinant(s) of ERGIC-53. 
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localization  of  overexpressed 
ERGIC-53 and GM. COS cells 
were mock-transfected (a and 
b),  or  transfected  with  ER- 
GIC-53  cDNA  (c  and  d)  or 
GM cDNA (e and]). 44 h after 
transfection  the  cells  were 
stained  before  fixation  and 
permeabilization  at 4°C (b,  d, 
and  f),  or  after  fixation  and 
permeabilization  (a,  c,  and  e) 
using  mAbs  G1/93  against 
ERGIC-53  or  9El0  against 
GM  (mAb  concentrations:  a, 
G1/93  1:50; b,  G1/93  1:10; c, 
G1/93 1:2,000; d, G1/93 1:10; e, 
9E10  1:50; f,  9El0  1:10)  fol- 
lowed  by  goat  anti-mouse 
FITC. Note that both cells in c 
are  transfected,  endogenous 
ERGIC-53  is  not  stained  at 
this  dilution  of  mAb  G1/93. 
Overexpression  of ERGIC-53 
or GM leads to cell surface ex- 
pression in some cells whereas 
all of the endogenous ERGIC- 
53  is  intracellular  in  mock- 
transfected cells. The intracel- 
lular patterns of overexpressed 
ERGIC-53  and  GM  are  very 
similar. Bar, 10 txm. 
Neither the Lumenal Nor the Transmembrane Domain 
Is Sufficient for Pre-medial-Golgi  Localization 
Within the secretory pathway there is precedence for tar- 
geting  mediated  by  lumenal,  transmembrane,  and  cyto- 
plasmic domains acting alone or in combination  (Nilsson 
et  al.,  1989; Munro,  1991;  Sweet and Pelham,  1992;  Pon- 
nambalam et al., 1994; Schweizer et al., 1994). To test the 
contribution to targeting of each domain of ERGIC-53 we 
have  chosen  human  CD4,  a  monomeric,  N-glycosylated 
plasma  membrane  protein  as  a  reporter.  To  test  suffi- 
ciency for correct targeting of the lumenal domain of ER- 
GIC-53 we replaced its transmembrane  with that of CD4 
and substituted the cytoplasmic domain with alanines (Fig. 
1., L53T4R2Alo). Targeting  sufficiency of the  transmem- 
brane domain was tested by replacing the transmembrane 
domain in CD4 by that of ERGIC-53 (Fig.  1, L4T53C4). 
The  requirement  for the  transmembrane  domain in ER- 
GIC-53  targeting  was  addressed  by  replacing  the  trans- 
membrane domain with that of CD4 (Fig. 1, L53T4C53). 
COS  cells  transfected  with  GM,  L53T4C53  and 
L53T4R2AI0 were pulsed for five min with [35S]methionine 
and chased for up to 2 h. The immunoprecipitated mutant 
proteins were digested with endo H  and the fraction of re- 
sistant  protein  determined  (Fig.  4  a).  GM  representing 
overexpressed  wild-type  ERGIC-53 showed  ~10%  endo 
H  resistance  after  1 h  of chase  (Fig. 4 a).  This value was 
identical to that obtained with an ERGIC-53 mutant con- 
taining  the  N-glycosylation site  but  no  epitope  tag  (not 
shown).  The  replacement  of the  transmembrane  domain 
in ERGIC-53 by CD4 (L53T4C53) did not change the ac- 
quisition of endo H  resistance, suggesting that it is not re- 
quired for targeting (Fig. 4 a). The inverse construct with 
the  ERGIC-53  transmembrane  domain  in  a  CD4  back- 
ground IAT53C4 showed similar kinetics of endo H  resis- 
tance (Fig. 4b) and comparable localization by immunoflu- 
orescence  (not  shown)  as  overexpressed  wild  type  CD4. 
This indicated that the transmembrane domain of ERGIC-53 
was not sufficient for the targeting of ERGIC-53. Substitu- 
tion of both the transmembrane  and the cytoplasmic do- 
mains (L53T4R2A10) resulted in ~50%  endo H  resistance 
after  1 h  of chase (Fig. 4 a). The lumenal domain of ER- 
GIC-53 is not sufficient for targeting. 
The Cytoplasmic Domain Is Sufficient 
for Pre-medial-Golgi  Localization  of a 
Reporter Protein 
The  above results  strongly argued for a  role  of the cyto- 
plasmic  domain  in  intracellular  targeting  of ERGIC-53, 
and to analyze this directly two CD4-ERGIC53 constructs 
were generated: IAT4C53, containing only the cytoplasmic 
domain, and IAT53C53 containing the cytoplasmic and the 
transmembrane domain of ERGIC-53 (Fig. 1). Transfected 
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Figure 3.  C-myc epitope tag and N-glycosylation site  are func- 
tional in modified ERGIC-53 (GM)  and do not interfere with oli- 
gomerization. COS cells were transfected with cDNAs encoding 
ERG1C-53 or GM. 44 h after transfection the cells were labeled 
for five min with [35S]methionine followed by a chase of 15 min, 
and  then subjected  to immunoprecipitation with  the indicated 
mAbs  (G1/93  against ERGIC-53, 9El0 against  the c-myc epi- 
tope). Where marked the samples were treated with endo H  to 
remove N-linked high-mannose glycans and  analyzed by SDS- 
PAGE (4-10% slab gel) under reducing (DTT+) or nonreducing 
(DTT-) conditions, followed by fluorography. Note that the ex- 
pression levels of overexpressed ERGIC-53 and GM are identi- 
cal and that no detectable endogenous ERGIC-53 is precipitated 
with the c-myc antibody. Numbers at the left margin indicate the 
position of molecular mass standards in kD. 
COS cells were analyzed by a double immunofluorescence 
procedure  which allowed  differential  staining  of the  cell 
surface and intracellular membranes (Fig. 5; see Materials 
and Methods). Overexpressed CD4 showed strong surface 
staining under nonpermeabilized  and a  perinuclear  intra- 
cellular staining under permeabilized conditions. The peri- 
nuclear staining most likely represents  newly synthesized 
protein in transit through the Golgi as well as internalized 
CD4 concentrated in endosomes and/or lysosomes. Over- 
expressed  CD4 chimera IAT53C53 and L4T4C53, on the 
other hand, showed no surface staining but a strong stain- 
ing  indicative  of the  ER:  reticular  intracellular  staining 
with a nuclear ring (Fig. 5, c-f). It is important to note that 
this  staining is distinct  from an ERGIC pattern  (see  also 
Fig. 8 B). For L4T4C53, a few cells exhibited surface stain- 
ing (insert in Fig. 5, e and f). To confirm these results bio- 
chemically, transfected  COS cells were pulse--chased and 
the immunoprecipitates  were digested with endo H  (data 
Figure 4.  ERGIC-53 lumenal  and  transmembrane  domain  are 
not  sufficient  for  targeting.  (a)  Transfected  COS  cells  were 
pulsed for five rain with [35S]methionine and chased for the indi- 
cated times with unlabeled methionine in excess followed by an 
immunoprecipitation with mAb 9El0 against the c-myc epitope. 
The  precipitates  were  digested  with  endo  H  and  analyzed by 
SDS-PAGE and fluorography. The amount of endo H-resistant 
protein was determined by laser scanner densitometry of fluoro- 
grams.  GM  (O),  L53T4C53  (A), L53T4RzA~0 ([2).  The values 
given are means ± SD of triplicate cultures treated in parallel.  (b) 
Transfected COS cells were pulsed for 15 min with [35S]methio- 
nine and chased for the indicated times with unlabeled methio- 
nine  in excess  followed by an  immunoprecipitation  with  mAb 
HP2/6 against CD4. The precipitates were digested with endo H 
and analyzed as described in a. Values are the average of two in- 
dependent experiments. Dark bars, CD4; Light bars, L4T53C4. 
not shown). In contrast to wild-type CD4, the chimeras re- 
mained endo H  sensitive after prolonged chase times indi- 
cating  a  pre-medial-Golgi  localization,  which  is  in  line 
with the ER-staining observed in Fig. 5. We conclude that 
the cytoplasmic domain of ERGIC-53 is sufficient for pre- 
medial-Golgi targeting. 
The Cytoplasmic Domain Contains Three 
Targeting Features 
To  define  the  targeting  signal(s)  in  the  cytoplasmic  do- 
main  of ERGIC-53,  amino  acids  were  serially  truncated 
from the COOH terminus.  Surprisingly, deletion of up to 
seven amino acids, which eliminated  the putative  KKXX 
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of endo H  resistance compared to wild type (Fig. 6, lines 2, 
3, 4, and 6). These results suggest that the inner five amino 
acids RSQQE  adjacent to the transmembrane domain act 
Figure  5.  Double-immunoflu- 
orescence  analysis  of  surface 
and intracellular CD4, 1_AT53C53 
and L4T4C53. Transfected COS 
cells were  cooled to 4°C  and 
incubated  with  mAb  6D10 
(IgG1), against CD4, followed 
by  IgGl-specific  goat  anti- 
mouse-FITC to stain protein at 
the cell surface  (b, d,  and f). 
The cells were then fixed and 
permeabilized followed by an 
incubation with mAb HP2/6.1 
(IgG2a),  against  CD4,  and 
goat  anti-mouse  IgG2a-spe- 
cific  goat  anti-mouse-TRITC 
staining the  intracellular pro- 
tein (a, c, and e). The DNA's 
used  were  CD4  (a  and  b), 
L4T53T53  (c  and  d)  and 
L4T4C53 (e and Y3- Bar corre- 
sponds to 10  ~m in a, b, c, d 
and 22 ~m in e and f. 
as a  targeting determinant. To exclude conformational ar- 
tifacts due to truncation, which might slow down exit from 
the ER, we restored the authentic tail length by re-adding 
seven alanines to the RSQQE, and we deleted the KKXX- 
motif in L53T4C53. Both constructs showed equal endo H 
resistance and oligomerization equal to wild type, strongly 
arguing against a truncation artifact (Fig. 6, lines 5 and 7). 
We  conclude  that  the  five residues RSQQE  adjacent  to 
the  transmembrane  domain  constitute  a  targeting  deter- 
minant. 
Figure  6.  The  cytoplasmic  domain  of  ERGIC-53  contains  a 
KKXX-retrieval signal and a second targeting signal adjacent to 
the membrane. Endo H resistance was determined after 5 rain of 
pulse with [35S]methionine  followed by 60  min of chase as de- 
scribed in Fig. 4 a. The mutations indicated were all constructed 
in a GM background, except mutation 5 that was constructed in 
L53T4C53  (see Fig. 1). The amino acid sequence of the cytoplas- 
mic domain is given in the single letter code with construct 1 rep- 
resenting the wild-type sequence. The values given are means + 
SD of triplicate cultures treated in parallel. Surface appearance 
of the overexpressed proteins was analyzed by indirect immuno- 
fluorescence microscopy staining the cell surface with mAb 9El0 
at 4°C before fixation and permeabilization as described in Fig. 2. 
(a) The cytoplasmic  domain of ERGIC-53 contains two targeting 
determinants. (b) The RSQQE determinant is suppressed by aro- 
mates in the -1/-2 position from the COOH terminus. (c) Lysine- 
specificity and position-dependence identify KKFF as a  KKXX 
ER-retrieval signal. 
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mic domain of ERGIC-53 (Fig. 6, line 9). A construct with 
two correctly positioned lysines (-3/-4  from the COOH 
terminus) but lacking the terminal phenylalanines did not 
acquire endo H  resistance and was not transported to the 
cell surface. This construct is significantly different from 
construct 1 (Fig. 6, wt), containing the terminal phenylala- 
nines and from construct 7 (Fig. 6) that contains only the 
RSQQE determinant. It also confirmed that transport of 
ERGIC-53 to the Golgi and the cell surface was not simply 
a  question  of  enforced  overexpression but  an  intrinsic 
property of the cytoplasmic domain. 
Introduction of the two COOH-terminal phenylalanine 
residues in absence of the lysines showed an unexpected 
increase in endo H resistance (Fig. 6, line 8) reflecting com- 
parable rates of transport as shown for L53T4R2AI0 and 
CD4  (Fig. 4). The phenylalanines suppress the targeting 
mediated by the RSQQE  determinant.  Comparison of a 
mutant with one lysine changed to serine, and the phenyl- 
alanines substituted by alanines (KSAA) to mutants with 
phenylalanines or tyrosines present in the -1/-2  position 
from the COOH terminus (KSFF, KSFY, KSYF, KSYY) 
showed that terminal phenylalanine/tyrosine residues sup- 
press the RSQQE determinant (Fig. 6, lines 10-14). 
To assess whether the KKFF sequence is a functional di- 
lysine ER-retrieval signal, we tested two criteria: lysine de- 
pendence and position dependence from the COOH ter- 
minus (Jackson et al., 1990). Both, the lysine dependence 
tested by substitution with arginines  (Fig 6, line 15)  and 
the position dependence from the COOH terminus tested 
by addition of three alanines to the COOH terminus (Fig. 
6, lines 16 and 17, and compare line 9 to 18) identified the 
KKFF-tetrapeptide as a di-lysine ER-retrieval signal. We 
conclude that the cytoplasmic domain of ERGIC-53 con- 
tains three targeting determinants: a di-lysine ER-retrieval 
signal, a RSQQE determinant adjacent to the membrane 
and two COOH-terminal phenylalanines which influence 
the RSQQE determinant. It is important to note that the 
overall folding of all  mutants  generated in  a  GM  back- 
ground was controlled by comparing their kinetics of oli- 
Figure 7.  The retrieval capacity of the di-lysine signal is reduced 
by the phenylalanines. Endo H resistance was determined as in Fig. 
5. Chase time was 5 h. All constructs were in a GM background 
containing the indicated cytoplasmic domains. Construct 1 corre- 
sponds to GM, and construct 2 is identical to construct 9 in Fig. 5. 
The values given are means -+ SD of triplicate cultures treated in 
parallel. 
gomerization to that of ERGIC-53. All mutants shown in 
this paper oligomerize identical to ERGIC-53. 
The COOH-terrainal Phenylalanines  Modulate the 
ER-retrieval Signal 
Besides  suppressing  the  inner  targeting  determinant  do 
the COOH-terminal phenylalanines also influence the di- 
lysine signal? Construct 9 in Fig. 6, which had the terminal 
phenylalanines replaced by alanines in the wild-type cyto- 
plasmic domain, was not transported to the medial-Golgi 
after 5 h of chase (Fig. 7, line 2). This result, however, did 
not allow us to conclude that the terminal phenylalanines 
influence the di-lysine motif since in that construct the in- 
ner targeting determinant was not suppressed and could 
have contributed to the intracellular targeting efficiency 
(compare Fig. 7, lines 1 and 2). However, substitution of 
the  phenylalanines  in  RRAAAAAAKKFF  by  atanines 
enabled us to determine the influence of the phenylala- 
nines on the di-lysine motif. The resulting construct with 
the  cytoplasmic amino  acid  sequence  RRAAAAAAK- 
KAA (Fig. 7, line 4) showed no significant ER to medial- 
Golgi transport  after 5  h  of chase  comparable to RSQ- 
QEAAAKKAA (Fig. 7, line 2). Both constructs showed 
expression levels identical to GM and displayed no surface 
staining  by  immunofluorescence  microscopy  (data  not 
shown). 
We  conclude that  COOH-terminal  phenylalanines  re- 
duce the ER-retrieval efficiency mediated by the di-lysine 
motif. 
Correct Targeting of  ERGIC-53 Requires 
the Entire Cytoplasmic Domain and the Presence 
of the Lumenal Domain 
As the endo H  assay cannot monitor localization within 
the ER-ERGIC-c/s-Golgi cycle we used immunofluores- 
cence microscopy of cells expressing moderate levels of 
protein to distinguish ER from ERGIC and Golgi. High 
expression levels lead to saturation of the recycling path- 
way and result in staining of the cell surface and the endo- 
somal  system, a  condition that  renders  a  morphological 
analysis impossible (see also Fig. 2). To determine the role 
of the cytoplasmic targeting signals in maintaining ERGIC- 
53 within the ER-ERGIC-cis-Golgi cycle, COS cells were 
transfected  with  the  cDNAs  corresponding to  the  con- 
structs  in  Fig.  7  with  the  cytoplasmic  domains:  RSQ- 
QEAAAKKFF (wild type), RSQQEAAAKKAA, RRA- 
AAAAAKKFF,  and  RRAAAAAAKKAA.  16  h  after 
transfection,  corresponding  to  a  threefold increased  ex- 
pression  of mutant  versus  endogenous ERGIC-53  (data 
not shown), mutant protein was selectively visualized with 
the  mAb  against  the  c-myc epitope.  Overexpression  of 
GM  with the cytoplasmic sequence RSQQEAAAKKFF 
lead to the characteristic concentrated perinuclear pattern 
(Fig. 8 A, a) observed for endogenous ERGIC-53 (Fig. 8 
B, b), whereas substitution of the terminal phenylalanines 
by alanines  (RSQQEAAAKKAA)  lead to a  typical ER 
pattern with a  pronounced staining of the nuclear enve- 
lope and less concentration in a perinuclear area (Fig. 8 A, 
b). This finding emphasizes the importance of the phenyl- 
alanines in targeting. Proteins terminating in RRAAAA- 
AAKKFF  and  RRAAAAAAKKAA  were  localized  to 
the nuclear envelope and a  reticular network in  the cell 
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cence  localization  of  GM  (a), 
RSQQEAAAKKAA (b), RRA- 
AAAAAKKFF (c), RR-AAAA- 
AAKKAA (d).  (B) Double im- 
munofluorescence  localization 
of  L4T4C53  (a)  with  endoge- 
nous  ERGIC-53  (b).  Trans- 
fected COS cells were subjected 
to indirect  immunofluorescence 
16 h after transfection.  Staining 
was  as described  in Fig. 2 with 
mAbs 9E10 (A, a-d) against the 
c-myc-epitope,  HP2/6  (B,  a) 
against  CD4  and  G1/93 (B,  b) 
against  endogenous ERGIC-53. 
Bar, 10 txm. 
periphery (Fig. 8 A, c and d). The finding that neither of 
the two ER-retrieval signals alone was capable of mediat- 
ing  wild-type  targeting  showed  the  requirement  for  the 
RSQQE determinant for targeting. Therefore, ERGIC-53 
localization requires all three features in the cytoplasmic 
domain  of ERGIC-53:  a  di-lysine  ER-retrieval  signal,  a 
RSQQE  targeting determinant and two COOH-terminal 
phenylalanines  modulating  both  targeting  determinants. 
That the different mutants show differences in their distri- 
bution  also argues against binding of the  mutants to cal- 
nexin or even endogenous ERGIC-53 via their  carbohy- 
drate moiety as an explanation for their targeting within 
the ER-ERGIC-cis-Golgi cycle. 
We have shown that virtually the entire cytoplasmic do- 
main is required for targeting of ERGIC-53, but is the cy- 
toplasmic domain of ERGIC-53 also sufficient for correct 
targeting of a reporter protein within the ER-ERGIC-cis- 
Golgi cycle? By double immunofluorescence microscopy 
the  pattern of L4T4C53 was compared with endogenous 
ERGIC-53 16 h after transfection. L4T4C53 showed mostly 
an ER  pattern with a  strong nuclear ring clearly distinct 
from endogenous ERGIC-53 (Fig. 8 B, a and b), while lo- 
calization of a  construct containing  both the cytoplasmic 
and the lumenal domain of ERGIC-53, L53T4C53, was in- 
distinguishable  from GM (not shown). This difference in 
localization may be due  to the  reduced  influence  of the 
RSQQE  determinant  in  the  CD4-chimera  L4T4C53.  In- 
deed  a  CD4-chimera  lacking  the  KKFF-retrieval signal, 
L4T4C53 (K-4stop), acquired 32% endo H resistance after 
1 h of chase (not shown) considerably more than the 12% 
for the corresponding mutation in L53T4C53 (Fig. 6, line 
5).  We  conclude  therefore  that  the  presence  of  the 
ERGIC-53  lumenal  domain  is  required  for  a  functional 
RSQQE determinant. 
Discussion 
Based on the acquisition of endo H  resistance and the lo- 
calization of ERGIC-53 mutants  expressed in  COS  cells 
we have established that both the cytoplasmic and the lu- 
menal domain of the protein are required for correct tar- 
The Journal of Cell Biology, Volume 131, 1995  64 geting of ERGIC-53. We have further shown under high 
and  confirmed under  low expression conditions  that  the 
cytoplasmic domain contains three targeting determinants: 
a  functional  di-lysine ER-retrieval  signal,  a  determinant 
RSQQE  adjacent to the membrane and two COOH-ter- 
minal phenylalanines that modulate both. 
Acquisition of Endo H Resistance Reflects Loss of 
Intracellular Retention of ERGIC-53 
Since endogenous ERGIC-53 has not been found in com- 
partments beyond the cis-Golgi we have exploited the ac- 
quisition of endo H resistance of the glycosylated ERGIC- 
53 variant GM as a principal measure for the rate of loss 
from the ER-ERGIC-cis-Golgi system. This assay reveals 
subtle changes in the overall retention of GM mutants in 
the pre-mediaI-Golgi  recycling pathway, provided the ex- 
pression levels of the different constructs are comparable, 
a condition that was met in our experiments. However, the 
assay does not discriminate between recycling of overex- 
pressed  ERGIC-53  (GM)  from post-medial-Golgi  com- 
partments and transport to the cell surface. Three findings 
argue against a major contribution of recycling from late 
Golgi sites. First, ER-localized GM in highly overexpress- 
ing  COS  cells failed to costain  with  FITC-ricin,  a  lectin 
recognizing  -(1,4)-linked  galactose  added  in  the  trans- 
Golgi  (not  shown).  Jackson  et  al.  (1993)  reported  ER 
staining  by  Helix  pomatia  lectin  (recognizing  terminal 
GalNAc)  and  peanut  lectin  (recognizing  terminal  Gal- 
(1,3)-GalNAc)  in  cells overexpressing an  O-glycosylated 
CD8/E19  chimeric  protein  possessing  a  di-lysine  ER- 
retrieval signal. While this result is evidence for recycling 
of a  di-lysine protein via the Golgi apparatus it does not 
necessarily indicate recycling from the trans-Golgi. Helix 
pomatia lectin recognizes terminal GalNAc added both in 
the cis-Golgi (Roth et al., 1994)  and the trans-Golgi (Roth, 
1984), and peanut lectin binds glycans in the medial-Golgi 
(Roth,  1987).  Second,  we  found  a  strict  correlation  be- 
tween the acquisition of endo H  resistance and mislocal- 
ization to the cell surface of the different mutant proteins. 
Third,  we  have  shown  that  ERGIC-53  contains  a  func- 
tional di-lysine ER-retrieval signal, and a  recycling path- 
way from the ERGIC and the cis-Golgi is consistent with 
the major localization of coatomer, the putative receptor 
for di-lysine signals (Oprins et al.,  1993;  Cosson and Le- 
tourneur,  1994;  Letourneur et al., 1994).  Collectively, our 
data  argue  against  ERGIC-53  recycling  from the  trans- 
Golgi to biosynthetically earlier compartments. We con- 
clude therefore that the acquisition of endo H  resistance 
reflects loss of intracellular retention of ERGIC-53. 
An alternative approach to characterize loss of intracel- 
lular targeting would be to record cell surface appearance 
of overexpressed ERGIC-53 mutants. However, transient 
overexpression of wild-type ERGIC-53 leads to cell sur- 
face  mislocalization  in  5-10%  of  the  transfected  cells 
(Kappeler et  al.,  1994).  Surface-mislocalized  ERGIC-53 
protein efficiently internalizes and internalization is strongly 
affected by mutations  in  the  cytoplasmic domain  (Kap- 
peler et al., 1994;  Itin et al., 1995).  As a consequence the 
amount of ERGIC-53 at the cell surface is a combined re- 
sult  of loss  of intracellular  targeting  and  internalization 
both of which can be differentially affected by mutations. 
These  considerations  invalidate  surface  appearance  of 
ERGIC-53 mutants as a measure for loss of intracellular 
targeting. 
Targeting of ERGIC-53 
We have analyzed the targeting of ERGIC-53 in two steps. 
First,  we  identified  the  signals  involved  in  pre-medial- 
Golgi localization by a  biochemical approach under high 
expression conditions, and second, we tested whether the 
signals defined by this assay were required for the correct 
localization of ERGIC-53 within the ER-ERGIC-cis-Golgi 
system. For this purpose we analyzed by immunofluores- 
cence  microscopy the  distribution  of mutant  ERGIC-53 
proteins expressed at moderate expression levels, which is 
three times on average the level of endogenous ERGIC- 
53. This second analysis confirmed that the signals identi- 
fled  under  high  expression conditions  are  true  targeting 
determinants and not simply an artefactual result due to 
excessive overexpression. 
Our  data  indicate  that  pre-medial-Golgi  targeting  of 
ERGIC-53 depends to a large extent on the retrieval ca- 
pacity  of the  di-lysine  signal  in  its  cytoplasmic domain, 
even though an RSQQE determinant and two COOH-ter- 
minal phenylalanines are required for correct localization 
within the ER-ERGIC-cis-Golgi recycling pathway. How- 
ever, the cytoplasmic domain alone is not sufficient to tar- 
get a monomeric reporter protein, L4T4C53, identically to 
endogenous ERGIC-53. A  comparison of the acquisition 
of  endo  H  resistance  between  monomeric  L4T4C53 
K(-4)stop and oligomeric L53T4C53 (K-4)stop, both lack- 
ing the KKFF ER-retrieval signal, is most consistent with 
the idea that the RSQQE determinant is reduced or non- 
functional in the monomeric background. But how could 
oligomerization influence the RSQQE determinant? Two 
of the four cysteine residues, which could potentially link 
ERGIC-53  oligomers  by  disulfide  bridges,  are  located 
within a 15-amino acid distance from the transmembrane 
domain.  Provided  these  cysteines  covalently  link  the 
ERGIC-53  oligomers  in  the  immediate  vicinity  of  the 
membrane, this could actually lead to a close apposition of 
the RSQQE determinants on the cytoplasmic side of the 
membrane. It is conceivable that such an apposition is re- 
quired for the RSQQE determinant to be functional, a sit- 
uation not mimicked in the monomeric reporter protein. 
It is not clear what kind of interaction is mediated by the 
RSQQE determinant.  It could act as an imperfect reten- 
tion signal slowing transit through the ERGIC and thereby 
contribute  to the steady-state distribution  of the protein. 
The fact that RSQQE is also functional when the trans- 
membrane domain in GM is exchanged with that of CD4 
in L53T4C53 indicates that this signal is not part of a trans- 
membrane retention determinant, and hence the retention 
mechanism appears to be unrelated  to that of Golgi pro- 
teins (Nilsson and Warren, 1994). 
A  different explanation for the involvement of the lu- 
menal domain in the targeting of ERGIC-53 could be a lu- 
menal interaction with other proteins as a consequence of 
ERGIC-53's function.  The  finding  of Arar  et  al.  (1995) 
that  ERGIC-53 is identical  to  an intracellular  mannose- 
specific lectin points to the possibility that ERGIC-53 may 
facilitate ER to Golgi transport of newly synthesized gly- 
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one downstream of calnexin (Hammond et al., 1994; Ham- 
mond  and  Helenius,  1994;  Helenius,  1994)  adding  an 
additional level of quality control in the maturation pro- 
cess of glycoproteins. Either of these functions would in- 
volve the lumenal domain. Ligand binding may exert an 
allosteric effect on the cytoplasmic domain modulating the 
interaction with coatomer and thereby regulate the cycling 
of ERGIC-53.  If so, a contribution of the lectin domain to 
sorting  would  only  be  apparent  at  moderate  expression 
levels  when  enough  ligand  is  available.  The  strong  ER 
staining  of highly  overexpressed  ERGIC-53  and  GM  as 
compared to the concentrated pattern seen under moder- 
ate expression would be consistent with this notion. 
Role of the Phenylalanines 
We observed that the COOH-terminal phenylalanines re- 
duce the ER-retrieval capacity of the di-lysine signal and 
substitution  of the  phenylalanines  in  ERGIC-53  by  ala- 
nines resulted in ER localization. Furthermore, consistent 
with  a  pre-Golgi  localization,  this  construct  when  ex- 
pressed  in LEC-1  cells,  which lack the medial-Golgi  en- 
zyme  N-acetylglucosaminyl  transferase,  did  not  become 
endoglycosidase D  sensitive and hence did not reach the 
cis-Golgi  site  where  mannosidase  I  trimming  occurs  (F. 
Kappeler,  C. Itin, and H.-P. Hauri, unpublished  observa- 
tions). This is in contrast to endogenous ERGIC-53,  a mi- 
nor fraction of which is localized to the cis-Golgi (Schwei- 
zer et al., 1988; Foguet, M., and H.-P. Hauri, unpublished 
observation). These  observations suggest  that in absence 
of the phenylalanines ERGIC-53  protein is efficiently re- 
trieved  before  reaching the cis-Golgi, while  in  the  pres- 
ence  of  the  phenylalanines  transport  to  the  cis-Golgi 
can  occur.  Subcellular  fractionation  experiments  indeed 
showed that endogenous ERGIC-53 is retrieved to the ER 
from two sites. A  major fraction directly recycles from the 
ERGIC without prior passage through the cis-Golgi, while 
a  minor fraction has access to the cis-Golgi (Foguet,  M., 
and H.-P. Hauri, unpublished observation). 
Based on our finding that the phenylalanines reduce the 
pre-Golgi targeting efficiency of the di-lysine ER-retrieval 
signals, we propose that they reduce the efficiency of rec- 
ognition of the di-lysine signal by coatomer in the ERGIC, 
and  thereby  allow  a  fraction  of ERGIC-53  to be  trans- 
ported to the cis-Golgi. 
Mechanism of ERGIC-53 Targeting 
In summary our data suggest a model for ERGIC-53  tar- 
geting that is based on an active di-lysine ER-retrieval sig- 
nal that acts together with the COOH-terminal phenylala- 
nines, the RSQQE determinant and the lumenal domain 
to allow a post-ER localization. Localization of ERGIC-53 
in the ER/ERGIC/cis-Golgi  system is a result of retrieval 
and retention. In line with the most recent suggestion that 
COP's may not be involved in anterograde transport but 
in  selective  retrieval  of di-lysine-signal-bearing  proteins 
(Letourneur et al.,  1994;  Pelham,  1994)  it  is conceivable 
that KKFF is a retrieval signal whose binding to COPs is 
weak due to the presence of two COOH-terminal phenyl- 
alanines. Reduced COP binding may result in less efficient 
retrieval  that in turn would shift  the overall distribution 
from ER to ERGIC. In contrast,  RSQQE  together with 
the  lumenal  domain  may function  as  a  retention  signal 
leading to the known concentration of protein ERGIC-53 
in the ERGIC. Subcellular fractionation and COP binding 
studies will be required  to test the role of the individual 
targeting determinants. 
We thank F. Kappeler for characterizing the initial glycosylation mutant 
of ERGIC-53 and K. Bucher for excellent technical assistance. We are in- 
debted  to  K.  Karjalainen  for  the  generous  gift  of  antibodies  and  the 
eDNA to human CD4; F. Sanchez for kindly providing mAb to CD4; and 
M. Spiess and K. Matter for providing the pECE and the pCB6 expression 
vector, respectively. We are grateful to A. D. Linstedt for helpful discus- 
sions and valuable comments throughout the project, and to T. Lithgow 
for critically reading the manuscript. 
This study was supported by the Kanton of Basel-Stadt and the Swiss 
National Science Foundation. 
Received for publication 13 February 1995 and in revised form 19 April 
1995. 
References 
Aoki, D., N. Lee, N. Yamaguchi, C. Dubois, and M. N. Fukuda. 1992. Golgi re- 
tention of a trans-Golgi membrane protein, galactosyltransferase, requires 
cysteine and  histidine residues within the  transmembrane  domain. Proc. 
Natl. Acad. Sci.  USA. 89:4319--4323. 
Afar, C.,  V. Carpentier, J.-P.  Le Cear, M. Monsigny, A. Legrand, and A.-C. 
Roche. 1995. ERGIC-53, a membrane protein of the ER-Golgi intermediate 
compartment is identical to MR60 an intracellular  mannose-specific lectin of 
myelomonocytic cells. J. Biol. Chem. 270:3551-3553. 
Brewer, C. B., and M. G. Roth. 1991. A  single amino acid change in the cyto- 
plasmic domain alters the polarized delivery of influenza virus hemaggluti- 
nin. Z  Cell Biol. 114:413-421. 
Burke, J., J. M. Pettitt, H. Schachter, M. Sarkar, and P. A. Gleeson. 1992. The 
transmembrane  and flanking sequences of  1,2-N-acetylglucosaminyltrans- 
ferase specify medial Golgi localization. J. Biol. Chem. 266:24433-24440. 
Carrera, C. A., F. Sanchez-Madrid, M. Lopez-Botet, C. Berabeu, and M. O. De 
Landazuri.  1987.  Involvement of  the  CD4  molecule in  a  post-activation 
event on T-cell proliferation. Eur. Z lmmunol. 17:179-186. 
Chavrier, P., R. G. Parton, H.-P. Hauri, K. Simons, and M. Zerial. 1990. Local- 
ization of low molecular weight GTP-binding proteins to exocytic and en- 
docytic compartments. Cell. 63:317-329. 
Colley, K. J., E. U. Lee, and J. C. Paulson. 1992. The signal anchor and stem re- 
gions of the beta-galactoside alpha 2,6-sialyltransferase may each act to lo- 
calize the enzyme to the Golgi apparatus. J. Biol. Chem. 267:7784-7793. 
Cosson, P., and F. Letourneur. 1994. Coatomer interaction with di-lysine endo- 
plasmic reticulum retention motifs. Science (Wash. DC). 263:1629-1631. 
Cullen, B. R. 1987. Use of eukaryotic expression technology in the functional 
analysis of cloned genes. Methods Enzymol, 152:684-704. 
Ellis, L, E. Clauser, D. O. Morgan, M. Edrey, R. A. Roth, and W. J. Rutter. 
1986. Replacement of insulin receptor tyrosine residue 1162 and 1163 com- 
prises insulin-stimulated kinase  activities and  uptake  of  2-deoxyglucose. 
Cell. 45:721-732. 
Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of mono- 
clonal antibodies specific for human c-myc proto-oncogene product. Mol. 
Cell, Biol. 5:3610--3616. 
Fiedler, K., and K. Simons. 1994. A  putative new class of animal lectins in the 
secretory pathway homologous to leguminose lectins. Cell. 77:625-626. 
Gaynor, E. C., S. T. Heesen, T. R. Graham, M. Aebi, and S. D. Emr. 1994. Sig- 
nal-mediated retrieval of membrane protein from the GoIgi to the ER in 
yeast. J. Cell Biol, 127:653-665. 
Hammond, C., and A. Helenius. 1994. Folding of VSV G protein: sequential in- 
teractions with BiP and calnexin. Science (Wash. DC). 266:456-458. 
Hammond, C., [. Braakman, and A. Helenius. 1994. Role of N-linked oligosac- 
charide recognition, glucose trimming, and calnexin in glycoprotein folding 
and quality control. Proc. NatL Acad. Sci.  USA. 91:913-917. 
Helenius, A. 1994. How N-linked oligosaccharides affect glycoprotein folding 
in the endoplasmic reticulum. Mol, Biol. Cell. 5:253-265. 
Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site- 
directed mutagenesis by overlap extension using the polymerase chain reac- 
tion. Gene (Amst.). 77:51-59. 
Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engi- 
neering genes without the use of restriction enzymes: gene splicing by over- 
lap extension. Gene (Amst.). 77:61-68. 
Itin, C., F. Kappeler, A. D. Linstedt, and H.-P Hauri. 1995. A novel endocytosis 
signal related to the KKXX ER-retrieval signal. EMBO J. 14:2250-2256. 
Jackson, M. R., T. Nilsson, and P. A. Peterson. 1990. Identification of a consen- 
sus motif of transmembrane proteins in the endoplasmic reticulum. EMBO 
J. 9:3153-3163. 
The Journal of Cell Biology, Volume 131,  1995  66 Jackson, M. R., T. Nilsson, and P. A. Peterson. 1993.  Retrieval of transmem- 
brane proteins to the ER. J. Cell Biol. 121:317-333. 
Kappeler, F.,  C.  Itin, R.  Schindler, and H.-P.  Hauri.  1994.  A  dual role for 
COOH-terminal lysine residues in pre-Golgi retention and endocytosis of 
ERGIC-53. J. Biol. Chem. 269:6279-6281. 
Laemmli, U. K.  1970.  Cleavage of structural proteins during assembly of the 
head of bacteriophage T4. Nature (Lond.). 227:68ff7585. 
Letourner, F., E. C. Gaynor, S. Hennecke, C. D6molli6re, R. Duden, S. D. Emr, 
H. Riezman, and P. Cosson. 1994. Coatomer is essential for retrieval of di- 
lysine-tagged  proteins to the ER. Cell, 79:119%1207. 
Linstedt, A. D., and H.-P. Hauri. 1993. Giantin, a novel conserved Golgi mem- 
brane protein containing a  cytoplasmic domain of at least 350 kDa. Mol, 
Biol. Cell. 4:679-693. 
Machamer, C. E., M. E. Grim, A. Esquela, S. W. Chung, M. Rolls, K. Ryan, and 
A. M. Swift. 1993. Retention of a cis-Golgi protein requires polar residues 
on one face of a predicted c~-helix in the transmembrane domain. Mol. Biol. 
Cell 4:695-704. 
Maddon, P. J., D. R. Littman, M. Godfrey, D. E. Maddon, L. Chess, and R. 
Axel. 1985. The isolation and nucleotide sequence of a cDNA encoding the 
T cell surface protein T4: a new member of the immunoglobulin gene family. 
Cell 42:94-104. 
Munro, S. 1991. Sequence within and adjacent to the transmembrane segment 
of alpha-2,6-sialyltransferase  specify Golgi retention. EMBO J. 10:3577-3588. 
Nilsson, T.,  M.  R. Jackson, and P.  A. Peterson.  1989.  Short cytoplasmic se- 
quences serve as retention signals for transmembrane proteins in the ER. 
Cell 58:707-718. 
Nilsson, T., and G. Warren. 1994. Retention and retrieval in the endoplasmic 
reticulum and the Golgi apparatus. Curr. Opin. Cell. Biol, 6:517-521. 
Nilsson, T., J. M. Lucocq, D. Mackay, and G. Warren. 1991. The membrane- 
spanning domain of beta-l,4-galactosyltransferase specifies trans-Golgi lo- 
calization. EMBO J. 10:3567-3575. 
Nilsson, T., P. Slusarewicz, M. H. Hoe, and G. Warren. 1993. Kin recognition. A 
model for retention of Golgi enzymes. FEBS Lett. 330:1-4. 
Nilsson,T., M. H. Hoe, P. Slusarewicz, C. Rabouille, R. Watson, F. Hunte, G. 
Watzele, E. G. Berger, and G. Warren. 1994. Kin recognition between me- 
dial Golgi enzymes in HeLa cells. EMBO J. 10:3567-3575. 
Oprins, A., R. Duden, T. E. Kreis, H. J. Geuze, and J. W. Slot. 1993. Beta-COP 
localizes mainly to the cis-Golgi side in exocrine pancreas. Z  Cell Biol. 121: 
49-59. 
Pelham, H. R. B. 1994. About turn for the COPs? CelL 79:1125-1127. 
Pelham, H.  R. B.,  and S. Munro.  1993.  Sorting of membrane proteins in the 
secretory pathway. Cell. 75:603-605. 
Ponnambalam, S., C. Rabouille, J. P. Luzio, T. Nilsson, and G. Warren. 1994. 
The TGN38 glycoprotein contains two nonoverlapping signals that mediate 
localization to the trans-Golgi network. J. Cell Biol. 125:253-268. 
Roth, J. 1984. Cytochemical localization of terminal N-acetyl-D-galactosamine 
residues in cellular compartments of intestinal Goblet cells: Implications for 
the topology of O-glycosylation.  J. Cell Biol. 98:399-406. 
Roth, J.  1987.  Subcellular organization of glycosylation in mammalian cells. 
Biochem. Biophys. Acta. 906:405-436. 
Roth, J., Y. Wang., A. Eckhardt, and R. L. Hill. 1994. Subcellular organization 
of the UDP-N-acetyl-D-galactosamine:polypeptide-N-actelygalactosaminyl- 
transferase-mediated O-glycosylation reaction  in  the  submaxillary gland. 
Proc. Natl. Acad. Sci.  USA. 91:8935-8939. 
Russo, R. N., N. L. Shaper, D. J. Taatjes, and J. H. Shaper. 1992. 1,4-galactosyl- 
transferase: a  short NH2-terminal fragment that includes the cytoplasmic 
and transmembrane domain is sufficient for retention. J.  Biol.  Chem.  267: 
9241-9247. 
Saraste, J., and K. Svensson. 1991. Distribution of the intermediate elements 
operating in ER to Golgi transport. J. Cell Sci.  100:415-430. 
Schindler, R., C. Itin, M. Zerial, F. Lottspeich, and H.-P. Hauri. 1993. ERGIC- 
53, a membrane protein of the ERGIC, carries an ER retention motif. Eur. 
Z  Cell.  Biol, 61:1-9. 
Schweizer, A., J. A. M. Fransen, T. B/ichi, L. Ginsel, and H.-P. Hauri.  1988. 
Identification, by a monoclonal antibody, of a 53-kD protein associated with 
a  tubular-vesicular compartment at the cis-side of the Golgi apparatus. J. 
Cell Biol. 108:1643-1653. 
Schweizer, A., J. A. M. Fransen, K. Matter, T. E. Kreis, L. Ginsel, and H.-P. 
Hauri. 1990. Identification of an intermediate compartment involved in pro- 
tein transport from the ER to the Golgi apparatus. Eur. J. Cell Biol. 53:185- 
196. 
Schweizer, A., K. Matter, C. M. Ketcham, and H.-P. Hauri. 1991. The isolated 
ER-Golgi intermediate compartment exhibits properties that are different 
from ER and c/s-Golgi. J. Cell Biol. 113:45-54. 
Schweizer, A., M. Ericsson, T. B~ichi, G. Griffiths, and H.-P. Hauri. 1993. Char- 
acterization of a novel 63kDa membrane protein: implications for the orga- 
nization of the ER-to-Golgi pathway. Z  Cell Sci. 104:671-683. 
Schweizer, A., J. Rohrer, H.-P. Hauri, and S. Kornfeld. 1994. Retention of p63 
in the ERGIC depends on the presence of all three of its domains and its 
ability to form oligomers. J. Cell BioL 126:25-39. 
Sweet, D. J., and H. R. B. Pelham. 1992. The Saccharomyces cerevisiae SEC20 
gene encodes a  membrane glycoprotein which is sorted by the HDEL re- 
trieval system. EMBO J. 11:423-432. 
Swift, A. M., and C. E. Machamer. 1991. A  Golgi retention signal in a mem- 
brane-spanning domain of coronavirus E1 protein. J. Cell Biol. 115:19-30. 
Tang, B. L., S. H. Wong, S. H. Low, and W. Hong. 1992. The transmembrane 
domain of N-glucosaminyltransferase I contains a Golgi retention signal. Z 
Biol. Chem. 267:10122-10126. 
Teasdale, R. D., G. D'Agostaro, and P. A. Gleeson. 1992. The signal for Golgi 
retention of bovine 131,4-galactosyltransferase is in the transmembrane do- 
main. J. Biol. Chem. 267:4084-4096. 
Townsley, F. M., and H. R. B. Pelham. 1994. The KKXX signal mediates re- 
trieval of membrane proteins from the Golgi to the ER in yeast. Eur. J.  Cell 
Biol. 64:211-216. 
Weisz, O. A., A. M. Swift, and C. E. Machamer.  1993.  Oligomerization of a 
membrane protein correlates with its retention in the Golgi complex. Z  Cell 
Biol. 122:1185-1196. 
Wong, S. H., S. H. Low, and W. Hong. 1992. The 17-residue transmembrane do- 
main of beta-galactoside alpha 2,6-sialyltransferase is sufficient for Golgi re- 
tention. J. Cell Biol. 117:245-258. 
Itin et al. Targeting of Protein ERGIC-53  67 